TSS
HALO icon

Two Sigma Securities’s Halozyme HALO Stock Holding History

Two Sigma Securities’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,500
Closed -$240K – 3217
2023
Q4 		$240K Buy
+6,500
New +$245K ﹤0.01% 2215

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Two Sigma Securities's HALO Position: Q3 2022 in Review

Two Sigma Securities sold out of Halozyme (HALO) in Q3 2022, closing a stake of 8,681 shares — an estimated $382K sold.

Two Sigma Securities first reported a position in HALO in Q2 2022 and held it in 1 quarter. The position peaked at $382K in Q2 2022. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

  • Two Sigma Securities reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Securities sold 8,681 Halozyme shares in Q3 2022, an estimated $382K.
  • Two Sigma Securities first reported a position in Halozyme in Q2 2022 and held it in 1 quarter.
  • Two Sigma Securities's Halozyme position peaked at $382K in Q2 2022.
  • 357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.